Non-invasive energy upconversion methods and systems
US-9526913-B2 · Dec 27, 2016 · US
US9238149B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9238149-B2 |
| Application number | US-201113230415-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2011 |
| Priority date | Mar 11, 2009 |
| Publication date | Jan 19, 2016 |
| Grant date | Jan 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention includes a method of treating and preventing a neurological disorder, such as Alzheimer's Disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period. Preferably, each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule (preferably daily) for a predetermined treatment period. The predetermined frequency, according to a preferred embodiment, is about 918 MHz with a specific absorption rate (SAR) of about 0.25 W/kg+/−2 dB. The predetermined absorption period of this preferred embodiment is about one hour. The treatment period is long-term, being greater than about 6 months and preferably between about 7 and 9 months.
Opening claim text (preview).
What is claimed is: 1. A method of treating and preventing a symptom associated with Alzheimer's Disease in a subject, wherein said symptom is associated with amyloid deposit or cognitive ability, comprising: positioning an electromagnetic field emitting source proximal to the subject; exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz; continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period greater that about three (3) days; and reversing or reducing cognitive impairment or amyloid aggregation in said subject, decreasing a rate of amyloid deposition, or enhancing cognitive performance in said subject based on said step of continuing exposure for greater than about three (3) days. 2. The method of claim 1 , wherein the predetermined frequency is about 918 MHz. 3. The method of claim 1 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg. 4. The method of claim 1 , wherein the predetermined absorption period is about one hour twice daily. 5. The method of claim 1 , wherein the predetermined treatment period is greater than about 4 months. 6. The method of claim 1 , wherein the predetermined treatment period is between about 7 and 9 months. 7. The method of claim 1 , wherein an enhancement of said cognitive performance in said subject is indicated by an enhancement of working or short-term memory performance of said subject. 8. A method of treating and preventing an amyloid-related neurological disorder in a subject thereof, comprising: positioning an electromagnetic field emitting source proximal to the subject; exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz; continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period greater than about three (3) days; and reversing or reducing cognitive impairment or amyloid aggregation in said subject, decreasing a rate of amyloid deposition, or enhancing cognitive performance in said subject based on said step of continuing exposure for greater than about three (3) days. 9. The method of claim 8 , wherein the predetermined frequency is about 918 MHz. 10. The method of claim 8 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg. 11. The method of claim 8 , wherein the predetermined absorption period is about one hour twice daily. 12. The method of claim 8 , wherein the predetermined treatment period is greater than about 4 months. 13. The method of claim 8 , wherein the predetermined treatment period is between about 7 and 9 months. 14. The method of claim 8 , wherein an enhancement of said cognitive performance in said subject is indicated by an enhancement of working or short-term memory performance of said subject. 15. A method of enhancing cognitive function in a normal, cognitively unimpaired subject, comprising: positioning an electromagnetic field emitting source proximal to the subject; exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz; continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period; and enhancing cognitive performance of said subject based on said step of continuing exposure for said predetermined treatment period, wherein said enhancing cognitive performance of said subject includes enhancing working memory performance of said subject. 16. The method of claim 15 , wherein the predetermined frequency is about 918 MHz. 17. The method of claim 15 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg. 18. The method of claim 15 , wherein the predetermined absorption period is about one hour twice daily. 19. The method of claim 15 , wherein the predetermined treatment period is greater than about three (3) days. 20. The method of claim 15 , wherein the predetermined treatment period is greater than about four (4) months.
Related publications grouped by family.
Answers are generated from the same data shown on this page.